Discover the detailed record of transactions filed by White Lauren, 首席财务官. Director active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 2 reports have been published. History available since 26 May 2022. The latest transaction was disclosed on 26 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
White Lauren is the Chief Financial Officer at C4 Therapeutics, Inc. She is responsible for managing the company's finances, including accounting and financial planning. Her role is essential in ensuring the financial health of C4 Therapeutics and supporting strategic decision-making. Her expertise in finance contributes to the overall performance of the company.